                         SEQUENCE LISTING

<110>  THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE 
       SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
 
<120>  ANTI-HUMAN ROR1 ANTIBODIES

<130>  706266

<150>  US 61/172,099
<151>  2009-04-23

<160>  20    

<170>  PatentIn version 3.5

<210>  1
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Antibody fragment dervied from Mus musculus hybridoma

<400>  1

Gln Val Gln Leu Gln Gln Ser Gly Ala Glu Leu Val Arg Pro Gly Ala 
1               5                   10                  15      


Ser Val Thr Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe Ser Asp Tyr 
            20                  25                  30          


Glu Met His Trp Val Ile Gln Thr Pro Val His Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Ala Ile Asp Pro Glu Thr Gly Gly Thr Ala Tyr Asn Gln Lys Phe 
    50                  55                  60                  


Lys Gly Lys Ala Ile Leu Thr Ala Asp Lys Ser Ser Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Arg Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Tyr Cys 
                85                  90                  95      


Thr Gly Tyr Tyr Asp Tyr Asp Ser Phe Thr Tyr Trp Gly Gln Gly Thr 
            100                 105                 110         


Leu Val Thr Val Ser Ala 
        115             


<210>  2
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Antibody fragment derived from Mus musculus hybridoma

<400>  2

Asp Ile Val Met Thr Gln Ser Gln Lys Ile Met Ser Thr Thr Val Gly 
1               5                   10                  15      


Asp Arg Val Ser Ile Thr Cys Lys Ala Ser Gln Asn Val Asp Ala Ala 
            20                  25                  30          


Val Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ser Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ser Ala Ser Asn Arg Tyr Thr Gly Val Pro Asp Arg Phe Thr Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Asn Met Gln Ser 
65                  70                  75                  80  


Glu Asp Leu Ala Asp Tyr Phe Cys Gln Gln Tyr Asp Ile Tyr Pro Tyr 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Leu Glu Ile Lys 
            100                 105         


<210>  3
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Antibody fragment derived from Mus musculus hybridoma

<400>  3

Gln Val Gln Leu Gln Gln Ser Gly Ala Glu Leu Val Arg Pro Gly Ala 
1               5                   10                  15      


Ser Val Thr Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe Ser 
            20                  25                  30  


<210>  4
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Antibody fragment derived from Mus musculus hybridoma

<400>  4

Asp Tyr Glu Met His 
1               5   


<210>  5
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Antibody fragment derived from Mus musculus hybridoma

<400>  5

Trp Val Ile Gln Thr Pro Val His Gly Leu Glu Trp Ile Gly 
1               5                   10                  


<210>  6
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Antibody fragment derived from Mus musculus hybridoma

<400>  6

Ala Ile Asp Pro Glu Thr Gly Gly Thr Ala Tyr Asn Gln Lys Phe Lys 
1               5                   10                  15      


Gly 
    


<210>  7
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Antibody fragment derived from Mus musculus hybridoma

<400>  7

Lys Ala Ile Leu Thr Ala Asp Lys Ser Ser Ser Thr Ala Tyr Met Glu 
1               5                   10                  15      


Leu Arg Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Tyr Cys Thr Gly 
            20                  25                  30          


<210>  8
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Antibody fragment derived from Mus musculu hybridoma

<400>  8

Tyr Tyr Asp Tyr Asp Ser Phe Thr Tyr 
1               5                   


<210>  9
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Antibody fragment derived from Mus musculu hybridoma

<400>  9

Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ala 
1               5                   10      


<210>  10
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Antibody fragment derived from Mus musculus hybridoma

<400>  10

Asp Ile Val Met Thr Gln Ser Gln Lys Ile Met Ser Thr Thr Val Gly 
1               5                   10                  15      


Asp Arg Val Ser Ile Thr Cys 
            20              


<210>  11
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Antibody fragment derived from Mus musculus hybridoma

<400>  11

Lys Ala Ser Gln Asn Val Asp Ala Ala Val Ala 
1               5                   10      


<210>  12
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Antibody fragment derived from Mus musculus hybridoma

<400>  12

Trp Tyr Gln Gln Lys Pro Gly Gln Ser Pro Lys Leu Leu Ile Tyr 
1               5                   10                  15  


<210>  13
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Antibody fragment derived from Mus musculus hybridoma

<400>  13

Ser Ala Ser Asn Arg Tyr Thr 
1               5           


<210>  14
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Antibody fragment derived from Mus musculus hybridoma

<400>  14

Gly Val Pro Asp Arg Phe Thr Gly Ser Gly Ser Gly Thr Asp Phe Thr 
1               5                   10                  15      


Leu Thr Ile Ser Asn Met Gln Ser Glu Asp Leu Ala Asp Tyr Phe Cys 
            20                  25                  30          


<210>  15
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Antibody fragment derived from Mus musculus hybridoma

<400>  15

Gln Gln Tyr Asp Ile Tyr Pro Tyr Thr 
1               5                   


<210>  16
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Antibody fragment derived from Mus musculus hybridoma

<400>  16

Phe Gly Gly Gly Thr Lys Leu Glu Ile Lys 
1               5                   10  


<210>  17
<211>  354
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  cDNA derived from Mus musculus hybridoma

<400>  17
caggttcaac tgcagcagtc tggggctgag ctggtgaggc ctggggcttc agtgacgctg       60

tcctgcaagg cttcgggcta cacattttct gactatgaaa tgcactgggt gattcagaca      120

cctgtgcatg gcctggaatg gattggagct attgatcctg aaactggtgg tactgcctac      180

aatcagaagt tcaagggcaa ggccatactg actgcagaca aatcctccag cacagcctac      240

atggagctcc gcagcctgac atctgaggac tctgccgtct attactgtac aggctactat      300

gattacgact cgtttactta ctggggccaa gggactctgg tcactgtctc tgca            354


<210>  18
<211>  354
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Optimized sequence for mammalian expression system

<400>  18
caagtgcagc ttcaacagtc tggggcagaa ctcgtaagac caggagcatc agtgacactg       60

tcttgtaaag cctccggcta taccttctct gactacgaga tgcattgggt catccagaca      120

ccagtacatg ggctcgaatg gataggagcc atagatccag agacaggcgg aacagcatac      180

aaccagaagt tcaaaggcaa ggccattctc acagcggaca agagcagtag caccgcttac      240

atggagttgc gatccctgac cagtgaggac tctgcagtct actattgtac agggtactat      300

gactacgact cattcacata ttgggggcag ggtaccttgg tgactgtctc cgct            354


<210>  19
<211>  321
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  cDNA derived from Mus musculus hybridoma

<400>  19
gacattgtga tgacccagtc tcaaaaaatc atgtccacaa cagtgggaga cagggtcagc       60

atcacctgca aggccagtca gaatgtggat gctgctgtag cctggtatca acagaaacca      120

ggacaatctc ctaaactact gatttactca gcatccaatc ggtacactgg agtccctgat      180

cgcttcacag gcagtggatc tgggacagat ttcactctca ccattagcaa tatgcagtct      240

gaagacctgg cagattattt ctgtcagcaa tatgacatct atccgtacac gttcggaggg      300

gggaccaagc tggaaataaa a                                                321


<210>  20
<211>  321
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Optimized sequence for mammalian expression system

<400>  20
gatatagtga tgacgcagtc ccagaagatc atgtccacga ccgtcgggga tcgggtcagt       60

ataacatgta aggcatccca gaacgtggac gcggccgtgg cttggtatca acagaaaccc      120

ggtcaatccc caaagctcct catctactct gcgagcaata gatataccgg tgtgcctgat      180

aggttcaccg gaagcggatc cggaacagat ttcaccctga ctatcagcaa tatgcaatcc      240

gaggacttgg ctgactactt ttgccagcaa tacgacatat acccctacac cttcggcgga      300

ggcacaaagc tcgagataaa g                                                321


